US Multiple Sclerosis Market 2015 - Size, Share, Growth & Forecast 2019 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

US Multiple Sclerosis Market 2015 - Size, Share, Growth & Forecast 2019

Description:

Big Market Research “Multiple Sclerosis Market in the US” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. – PowerPoint PPT presentation

Number of Views:71

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: US Multiple Sclerosis Market 2015 - Size, Share, Growth & Forecast 2019


1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Multiple Sclerosis Market in the US 2015-2019
Growth, Global Share, Industry Overview,
Analysis, Trends Opportunities and Forecast
2
Description
Report Overview
About Multiple Sclerosis   Multiple sclerosis is
a chronic, inflammatory medical condition, which
results in demyelination, axonal transection, and
neurodegeneration of the nerve cells of the brain
and spinal cord. The immune system of the body
targets the neurons within the CNS and damages
the myelin sheath. It is a potentially
debilitating disease, causing disruption in the
communication and coordination functions of the
body. The symptoms of multiple sclerosis differ
widely, subject to the extent of damage and the
number of neurons affected. Some of the symptoms
observed are fatigue, numbness, spasticity,
bladder dysfunction, cognitive changes, emotional
changes, and depression. An individual with
severe form of the disease can experience speech
and movement problems. Multiple sclerosis can be
broadly classified into four types RRMS, SPMS,
PPMS, and PRMS. The multiple sclerosis market
in the US to grow at a CAGR of 3.8 over the
period 2014-2019.   Read more details at
http//www.bigmarketresearch.com/multiple-sclerosi
s-in-the-us-2015-2019-market
3
Key Benefits
Summery
Covered in this Report   The multiple sclerosis
market, report covers the present scenario and
the growth prospects of the multiple sclerosis
market in the US for the period 2015-2019. To
calculate the market size, the report considers
revenue generated from sales of various drugs
used in the treatment of multiple sclerosis.  On
the basis of route of administration of the
drugs, the market is grouped into the following
categories Oral Parenteral On the basis of
type of molecule of the drugs, the market is
grouped into the following categories Small
Molecules Biologics  The report also presents
the vendor landscape and a corresponding detailed
analysis of the top vendors and competitive
performances of their product portfolios in the
market. In addition, it discusses the major
drivers that influence the growth of the market.  
4
Key Audiences
Key Vendors Bayer AG Biogen Merck Serono
Novartis AG Teva Pharmaceutical Industries
Ltd.  Other Prominent Vendors AB Science
Abbvie Acorda Therapeutics Active Biotech
Artielle Astellas AstraZeneca Canbex F.
Hoffmann-La Roche GeNeuro GlaxoSmithKline
5
Table Of Contents
Company Profile
Market Driver Unmet Medical Needs. For a
full, detailed list, view our report.   Market
Challenge Unknown Disease Etiology. For a
full, detailed list, view our report.   Market
Trend Introduction of Disease-modifying
Drugs. For a full, detailed list, view our
report. Enquire about report http//www.bigmarke
tresearch.com/report-enquiry/250865
6
Get Full Information At http//www.bigmarketrese
arch.com/multiple-sclerosis-in-the-us-2015-2019-ma
rket
About PowerShow.com